Kohlmann Grünstein Shmulevich (KGS) is a deep tech venture capital firm with offices in New York, Zurich, and Singapore. The firm partners with entrepreneurs who are looking to leverage cutting-edge, IP-centered technology to solve some of humanity's greatest challenges, including applications in neuro-tech, bioengineering, advanced materials, clean energy, and photonics. The firm is deeply embedded in global networks of next-generation entrepreneurs, VCs, industry experts, and world-leading academic institutions. With over 30 years of combined venture capital and entrepreneurship experience across multiple continents, its founders understand both sides of investing and building, creating a uniquely global and founder-support-centric firm. Prior investments include CTRL-labs, a brain-machine-interface startup acquired by Meta (Facebook), Spiden, builder of a continuous, non-invasive biomarker monitoring platform, HyPoint, developer of high-temperature hydrogen fuel cells acquired by ZeroAvia, and Canaery, a nose-computer-interface company working on digitizing scent.